Johns Hopkins Antibiotic (ABX) GuideBrand Names

Diloxanide furoate

Paul A. Pham, Pharm.D. BCPS, Kathryn Dzintars, Pharm.D., BCPS
Diloxanide furoate is a topic covered in the Johns Hopkins Antibiotic (ABX) Guide.

To view the entire topic, please or purchase a subscription.

Johns Hopkins Guides provide diagnosis, management, and treatment guidance for infectious diseases, diabetes, and psychiatric conditions. Explore these free sample topics:

Johns Hopkins Guides

~~ The first section of this topic is shown below ~~

INDICATIONS

FDA

  • Drug not currently available for use in the U.S.
    • Also known as in the literature as entamide furoate or entamide.
  • CDC conducted a study with investigational use of the drug between 1977-1990.

NON-FDA APPROVED USES

  • Amebiasis limited to the GI lumen, caused by Entamoeba histolytica.
  • As combination therapy with other antiprotozoals such as nitroimidazoles for the treatment of invasive or extraintestinal amebiasis. Diloxanide furoate is not a tissue amoebicide and therefore in extraintestinal infections of E. histolytica, another agent (specifically a "tissue amoebicide" like Metronidazole) should be considered for use in combination with diloxanide furoate.

~~ To view the remaining sections of this topic, please
or purchase a subscription ~~

Last updated: January 13, 2016